Literature DB >> 23521914

Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE.

Alessandro S Farias1, Gabriela S Spagnol, Pedro Bordeaux-Rego, Camila O F Oliveira, Ana Gabriela M Fontana, Rosemeire F O de Paula, Mariana P A Santos, Fernando Pradella, Adriel S Moraes, Elaine C Oliveira, Ana Leda F Longhini, Alexandre C S Rezende, Mauro W Vaisberg, Leonilda M B Santos.   

Abstract

BACKGROUND: A growing body of evidence supports the hypothesis that vitamin D is an important environmental factor in the etiology of T-cell-mediated autoimmune diseases such as multiple sclerosis (MS). AIM: The purpose of this study was exploring the mechanisms underlying the beneficial effect of vitamin D3 in encephalomyelitis (EAE).
METHODS: We treated monophasic experimental autoimmune EAE, induced in Lewis rat, with vitamin D3 and adoptively transfer tolerogenic bone marrow-derived DCs generated in the presence of vitamin D3.
RESULTS: This study provides evidence that the in vivo administration of vitamin D3, as well as the adoptive transfer of vitamin D3 -induced IDO(+) immature/tolerogenic dendritic cells, leads to a significant increase in the percentage of CD4(+) CD25(+) Foxp3(+) regulatory T cells in the lymph nodes in a rat model of MS, experimental autoimmune EAE. Concomitant with the increase in this cell population, there is a significant decrease in the number of autoreactive T cells in the central nervous system. Bone marrow-derived DCs cultivated in the presence of vitamin D3 present a tolerogenic profile with high IL-10, TNFα, and IDO expression and decreased MHC-II and CD80 expression. The adoptive transfer of IDO (+) DCs induces a significant increase in the percentage of CD4(+) CD25(+) Foxp3(+) T cells in the lymph nodes, comparable with vitamin D3 treatment.
CONCLUSION: These mechanisms contribute actively to the generation of a microenvironment in the lymph nodes that suppresses the activation of encephalitogenic T cells, resulting in the downregulation of the inflammatory response in the central nervous system.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23521914      PMCID: PMC6493393          DOI: 10.1111/cns.12071

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  56 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells.

Authors:  Zhongxiang Xie; Jingtao Chen; Chao Zheng; Jing Wu; Yun Cheng; Shan Zhu; Chenhong Lin; Qingqing Cao; Jie Zhu; Tao Jin
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

3.  Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance.

Authors:  Liam M Casey; Ryan M Pearson; Kevin R Hughes; Jeffrey M H Liu; Justin A Rose; Madeleine G North; Leon Z Wang; Mei Lei; Stephen D Miller; Lonnie D Shea
Journal:  Bioconjug Chem       Date:  2017-11-30       Impact factor: 4.774

Review 4.  Vitamin D Deficiency and Rheumatoid Arthritis.

Authors:  Larissa Lumi Watanabe Ishikawa; Priscila Maria Colavite; Thais Fernanda de Campos Fraga-Silva; Luiza Ayumi Nishiyama Mimura; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Larissa Doddi Marcolino; Marcimara Penitenti; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

5.  Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis.

Authors:  Thais F C Fraga-Silva; Luiza A N Mimura; Sofia F G Zorzella-Pezavento; Larissa L W Ishikawa; Thais G D França; Rodolfo Thomé; Liana Verinaud; Maria S P Arruda; Alexandrina Sartori
Journal:  CNS Neurosci Ther       Date:  2016-06-19       Impact factor: 5.243

6.  Tolerogenic dendritic cells induced by BD750 ameliorate proinflammatory T cell responses and experimental autoimmune encephalitis in mice.

Authors:  Yan Zhou; Xiao Leng; Hua Li; Shuxia Yang; Tai Yang; Limei Li; Ying Xiong; Qiang Zou; Yang Liu; Yantang Wang
Journal:  Mol Med       Date:  2017-09-27       Impact factor: 6.354

7.  Activation of the STING adaptor attenuates experimental autoimmune encephalitis.

Authors:  Henrique Lemos; Lei Huang; Phillip R Chandler; Eslam Mohamed; Guilherme R Souza; Lingqian Li; Gabriela Pacholczyk; Glen N Barber; Yoshihiro Hayakawa; David H Munn; Andrew L Mellor
Journal:  J Immunol       Date:  2014-05-05       Impact factor: 5.422

Review 8.  Regulatory dendritic cell therapy: from rodents to clinical application.

Authors:  Dalia Raïch-Regué; Megan Glancy; Angus W Thomson
Journal:  Immunol Lett       Date:  2013-12-04       Impact factor: 3.685

9.  Immunosuppressive mechanisms of regulatory dendritic cells in cancer.

Authors:  Galina V Shurin; Yang Ma; Michael R Shurin
Journal:  Cancer Microenviron       Date:  2013-06-09

10.  Evidence for the Importance of Vitamin D Status in Neurologic Conditions.

Authors:  Anusha K Yeshokumar; Deanna Saylor; Michael D Kornberg; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.